Literature DB >> 12401314

Erythropoiesis and iron.

I Cavill1.   

Abstract

Iron and erythropoiesis are inextricably linked. Erythropoiesis is a dynamic process that requires 30-40 mg of iron per day. In normal circumstances this is met from red cell destruction but in anaemia this will not be the case. Reduced iron stores will limit iron supply to erythroblasts but normal or raised iron stores may not be able to supply iron fast enough. This is particularly true when the marrow is stimulated by erythropoietin therapy; the most common cause of failure to respond is "functional iron deficiency"'. This entity can only be effectively addressed by intravenous iron therapy. While haemoglobin and serum ferritin concentrations reflect the major iron pools, iron supply to erythroid cells can only be assessed by measuring effective haemoglobinization through the percentage of hypochromic red cells in the circulation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12401314     DOI: 10.1016/s1521-6926(02)90004-6

Source DB:  PubMed          Journal:  Best Pract Res Clin Haematol        ISSN: 1521-6926            Impact factor:   3.020


  12 in total

Review 1.  The diagnostic plot: a concept for identifying different states of iron deficiency and monitoring the response to epoetin therapy.

Authors:  Christian Thomas; Andreas Kirschbaum; Dieter Boehm; Lothar Thomas
Journal:  Med Oncol       Date:  2006       Impact factor: 3.064

2.  Novel serum biomarkers for erythropoietin use in humans: a proteomic approach.

Authors:  Britt Christensen; Lucila Sackmann-Sala; Diana Cruz-Topete; Jens Otto L Jørgensen; Niels Jessen; Carsten Lundby; John J Kopchick
Journal:  J Appl Physiol (1985)       Date:  2010-10-21

Review 3.  Stimulating erythropoiesis in inflammatory bowel disease associated anemia.

Authors:  Georgia Tsiolakidou; Ioannis-E Koutroubakis
Journal:  World J Gastroenterol       Date:  2007-09-28       Impact factor: 5.742

Review 4.  Iron, anaemia, and inflammatory bowel diseases.

Authors:  C Gasche; M C E Lomer; I Cavill; G Weiss
Journal:  Gut       Date:  2004-08       Impact factor: 23.059

5.  Crosstalk between Iron Metabolism and Erythropoiesis.

Authors:  Huihui Li; Yelena Z Ginzburg
Journal:  Adv Hematol       Date:  2010-06-10

Review 6.  Iron homeostasis in the liver.

Authors:  Erik R Anderson; Yatrik M Shah
Journal:  Compr Physiol       Date:  2013-01       Impact factor: 9.090

7.  Epoetin beta pegol (C.E.R.A.) promotes utilization of iron for erythropoiesis through intensive suppression of serum hepcidin levels in mice.

Authors:  Yusuke Sasaki; Mariko Noguchi-Sasaki; Yukari Matsuo-Tezuka; Yuki Matsumoto-Omori; Mitsue Kurasawa; Keigo Yorozu; Yasushi Shimonaka
Journal:  Int J Hematol       Date:  2014-03-13       Impact factor: 2.490

8.  Pro- and anti-inflammatory cytokines during immune stimulation: modulation of iron status and red blood cell profile.

Authors:  A M Koorts; P F Levay; P J Becker; M Viljoen
Journal:  Mediators Inflamm       Date:  2011-03-24       Impact factor: 4.711

9.  Increased preoperative collection of autologous blood with recombinant human erythropoietin therapy in tertiary care hospitals of Jammu.

Authors:  Kumkum Sharma; Sumit B Sharma; Imran A Pukhta; Amit B Sharma; Abdul Q Salaria
Journal:  Asian J Transfus Sci       Date:  2013-01

10.  An insight into the changes in human plasma proteome on adaptation to hypobaric hypoxia.

Authors:  Yasmin Ahmad; Narendra K Sharma; Iti Garg; Mohammad Faiz Ahmad; Manish Sharma; Kalpana Bhargava
Journal:  PLoS One       Date:  2013-07-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.